Skip to content
Open access

Integrated gut microbiome and fecal metabolome profiling identifies taurine-associated microbial dysbiosis across the Alzheimer’s disease clinical spectrum

Oct 2026 · Frontiers in Aging Neuroscience · Vol 18 · 0 citations · 41 references
Medicine

TL;DR

Integrated multi-omic profiling reveals coordinated microbiome–metabolome dysregulation across the AD clinical spectrum, with taurine as a candidate microbial–metabolic node linking gut dysbiosis to cognitive performance.

Abstract

Background Gut microbiome alterations have been associated with Alzheimer’s disease (AD), but how microbial composition, fecal metabolites, and cognitive function relate across the cognitive impairment spectrum—from subjective cognitive decline (SCD) through mild cognitive impairment (MCI) to AD—remains unclear. We integrated microbiome and metabolome profiles across this clinical spectrum. Methods Fecal samples from 84 participants [10 healthy controls (HC), 22 SCD, 23 MCI, 29 AD] underwent 16S rRNA V3–V4 sequencing and untargeted LC–MS metabolomics. Profiles were integrated via Procrustes analysis, sparse canonical correlation, MIMOSA2 community-metabolism modeling, and mediation analysis. Differential abundance was assessed by Kruskal–Wallis, ANCOM-BC2, and LinDA. Results Microbial composition differed across groups (ANOSIM R = 0.111, p = 0.001; Adonis R2 = 0.070, p = 0.002). Cross-method validation confirmed 8 differentially abundant genera in AD vs. HC with 100% directional concordance between ANCOM-BC2 and LinDA, including depletion of butyrate-producing Lachnospiraceae (Blautia, Dorea, Fusicatenibacter) and enrichment of opportunistic pathobionts (Klebsiella, Escherichia-Shigella). Taurine showed the highest MIMOSA2 community-prediction R2 (0.129; n = 62) and was positively associated with MMSE scores (r = 0.45, BH-FDR Q = 0.0005). A multi-omic random forest model (5 genera + 5 metabolites + age + sex) discriminated AD-clinical spectrum participants from HC with AUC = 0.86 (95% CI 0.82–0.90), although pairwise differences from the age + sex baseline (AUC = 0.75) did not reach statistical significance. Statistical mediation analysis was consistent with a Blautia → taurine → MMSE statistical mediation [ACME = 0.21, p = 0.008; 54% proportion mediated, bootstrap 95% CI (9%, 58%)]. Conclusion Integrated multi-omic profiling reveals coordinated microbiome–metabolome dysregulation across the AD clinical spectrum, with taurine as a candidate microbial–metabolic node linking gut dysbiosis to cognitive performance. Microbial and metabolic alterations are detectable at the SCD stage, before objective cognitive impairment. These findings warrant validation in larger, age-matched cohorts and higher-resolution metagenomic studies.

Read PDF

Similar papers

Open access Oct 2026

Parsing the relationships among gut microbiome, neurotransmitter metabolome, glymphatic function, and cognition across healthy elderly, mild cognitive impairment, and probable Alzheimer's disease.

BACKGROUND Evidence has suggested brain glymphatic dysfunction and gut microbial metabolic disturbance in Alzheimer's disease (AD), yet the relationships among gut microbiota, neurotransmitter metabolites, glymphatic function, and cognition across clinically defined groups of healthy elderly, mild cognitive impairment...

Chao Tao, K. Wan, Yu Song et al. · 0 citations
Review Open access Oct 2026

Microbiome-targeted strategies for Alzheimer’s disease: multi-omics signatures, mechanistic links, and intervention evidence

Alzheimer’s disease (AD) is increasingly studied in relation to gut microbial mechanisms because microbial metabolism, mucosal barrier function, and peripheral immune activation may influence neuroinflammation and host metabolic stress. This review evaluates microbiome-linked evidence in AD with emphasis on studies tha...

Xu-Yang Huang, Xin-Yue Zhang, Qi Zhu · 0 citations
Open access Oct 2026

Gut Microbiome Alterations in Alzheimer’s Disease: A Shotgun Metagenomic Case–Control Study

AD in this Central Asian cohort was associated with a less diverse, compositionally distinct gut microbiome, with depletion of butyrate-producing Firmicutes and enrichment of sulfate-reducing taxa, alongside other taxa whose direction of association differed from prior reports.

A. Issilbayeva, S. Kozhakhmetov, A. Kushugulova et al. · 0 citations
Open access Nov 2026

Four-axis fecal metabolome alterations and an exploratory 5-metabolite signature for detecting subjective cognitive decline across the clinically defined Alzheimer's disease spectrum

The gut-brain axis is implicated in Alzheimer's disease (AD), but fecal metabolomic changes across the healthy controls (HC)→subjective cognitive decline (SCD)→mild cognitive impairment (MCI)→AD clinical spectrum, especially at the SCD stage, remain poorly characterized. Without amyloid/tau confirmation, our groups...

Yi Feng, Rong-Qin Wu, Yu-Ming Chen et al. · 0 citations
Open access Nov 2026

Integrated multi-omics analysis reveals distinct metabolic signatures and gut microbiome alterations across the pediatric obesity spectrum

ABSTRACT Pediatric obesity drives extensive metabolic remodeling across gut and systemic compartments, yet integrated multi-omics characterization across the full obesity spectrum remains incomplete. We studied 57 Mexican children stratified by BMI into normal weight (NW, n = 15), overweight (Ow, n = 8), and obese (Ob,...

R. Arredondo-Hernández, Patricia Orduña, Alejandro Schcolnik-Cabrera et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.